COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,700,006 | -17.7% | 3,558,975 | 0.0% | 4.18% | -29.7% |
| Q2 2023 | $42,138,264 | +41.5% | 3,558,975 | +29.0% | 5.94% | +16.0% |
| Q1 2023 | $29,769,340 | -6.7% | 2,758,975 | 0.0% | 5.12% | +1.2% |
| Q4 2022 | $31,893,751 | -22.5% | 2,758,975 | 0.0% | 5.06% | -30.1% |
| Q3 2022 | $41,164,000 | +65.4% | 2,758,975 | 0.0% | 7.24% | +27.0% |
| Q2 2022 | $24,886,000 | +113.1% | 2,758,975 | +77.0% | 5.70% | +106.3% |
| Q1 2022 | $11,677,000 | -12.7% | 1,558,975 | 0.0% | 2.76% | -37.4% |
| Q4 2021 | $13,376,000 | +2.0% | 1,558,975 | 0.0% | 4.41% | -7.5% |
| Q3 2021 | $13,111,000 | +3.7% | 1,558,975 | 0.0% | 4.77% | -8.3% |
| Q2 2021 | $12,643,000 | -7.6% | 1,558,975 | 0.0% | 5.20% | -9.9% |
| Q1 2021 | $13,688,000 | -21.8% | 1,558,975 | 0.0% | 5.77% | -7.8% |
| Q4 2020 | $17,507,000 | – | 1,558,975 | – | 6.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,631,042 | $54,902,659 | 8.08% |
| Saturn V Capital Management LP | 1,775,415 | $17,310,296 | 7.24% |
| COMMODORE CAPITAL LP | 5,566,026 | $54,268,754 | 6.34% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $4,889,918 | 6.28% |
| VR Adviser, LLC | 4,684,167 | $45,670,628 | 4.81% |
| Fairmount Funds Management LLC | 3,558,975 | $34,700,006 | 4.18% |
| Kynam Capital Management, LP | 2,210,125 | $21,548,719 | 3.52% |
| Vivo Capital, LLC | 2,244,941 | $21,888,175 | 2.40% |
| 5AM Venture Management, LLC | 790,440 | $7,706,790 | 2.22% |
| Ghost Tree Capital, LLC | 650,000 | $6,337,500 | 2.08% |